Insmed Inc (INSM)
Healthcare
Biotechnology
98.50 $
-0.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Insmed Inc (INSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -223 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -123 | -136 | -131 | -184 | -123 | -181 | -196 | -262 | -206 | -220 | -248 | -223 | -896 | |
| 2.6 | 2.8 | 2.7 | 2.9 | 2.7 | 2.7 | 2.7 | 3.1 | 3.7 | 4.0 | 5.6 | 5.0 | 18 | |
| 18 | 20 | 20 | 21 | 23 | 26 | 27 | 39 | 43 | 31 | 39 | 46 | 159 | |
| 38 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2.2 | -24 | 7.7 | -55 | 40 | -16 | 28 | -66 | 9.5 | 14 | -38 | -64 | -78 | |
| 4.9 | 2.9 | 2.2 | 4.7 | 6.8 | 3.7 | 6.8 | 10 | 3.5 | 2.4 | 47 | 3.5 | 56 | |
| -274 | 7.1 | 1.8 | 295 | -6.8 | -1,003 | 132 | 80 | 228 | -762 | 389 | 266 | 121 | |
| 45 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.0 | – | – | – | – | -0.7 | 149 | -0.7 | -2.7 | -0.7 | -0.8 | -0.8 | -5.0 | |
| 44 | 1.2 | 123 | 3.0 | 781 | 397 | 159 | 29 | 858 | 33 | 34 | 30 | 955 | |
| -356 | -126 | -4.7 | 113 | 651 | -785 | 94 | -152 | 881 | -950 | 176 | 72 | 179 | |
| -128 | -139 | -133 | -189 | -130 | -185 | -203 | -272 | -209 | -222 | -294 | -226 | -952 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.